intrahepatic cholangiocarcinoma
Conditions
Interventions
operation group:R1/R2 resection
radiotherapy group:Stereotactic radiotherapy
chemotherapy:Fluorouracil and gemcitabine chemotherapy
control group:none
Sponsors
Nanfang Hospital, Southern Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with stage 4 TNM Confirmed by histology or cytology, or clinical diagnosis of ICC.
Exclusion criteria
Exclusion criteria: 1. Patients received any form of antineoplastic therapy before surgery: radiotherapy, chemotherapy, or biological therapy; 2. Patients with severe cardiovascular and cerebrovascular diseases which may have an impact on the expected life cycle; 3. Patients who have or are suffering from other malignancies, or who have been treated for cancer within 3 years, have the following conditions: cured cervical cancer, basal cell carcinoma of the skin and superficial bladder cancer (Ta,Tis,T1); 4. Patients with multiple metastasis of the body, and poor fluid quality, who are expected to survive for no more than 6 months of the patient; 5. Patients who did not complete the chemoradiotherapy regimen as planned.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Countries
China
Contacts
Public ContactZhang Guowei
Nanfang Hospital, Southern Medical University
Outcome results
None listed